Our current study shows that hPMSC-Exo carrying miR-21 could upregulate the expression of PTEN/PI3K-Nrf2 signaling pathway in senescent CD4+ T cells, improve the antioxidant capacity of CD4+ T cells, and alleviate age-related immune dysfunction. The gene discussed is NFE2L2; the disease is immune system disorder.